Interferon-α combined with radiotherapy in the treatment of unresectable melanoma

被引：3
|
作者：
Nguyen, NP
Sallah, S
Childress, C
Salehpour, MR
Karlsson, U
机构：
[1] SW Texas State Univ, VA N Texas Hlth Care Syst, Dept Radiat Oncol, Dallas, TX 75216 USA
[2] Univ Tennessee, Div Hematol Oncol, Memphis, TN 38163 USA
[3] Leo Jenkins Canc Ctr, Dept Radiat Oncol, Greenville, NC USA
来源：
CANCER INVESTIGATION | 2001年 / 19卷 / 03期
关键词：
D O I：
10.1081/CNV-100102553
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A case of recurrent and twice resected sinonasal melanoma is presented. The large recurrent tumor was found to regress by a concurrent combination of 6660 cc!: photon radiation and subcutaneous interferon-alpha injections given for a period of 8 weeks. Possible mechanisms of potentiation between interferon and radiation are discussed The unexpected result in this case report raises interesting questions about this treatment combination.
引用
收藏
页码：261 / 265
页数：5
相关论文
共 50 条
  • [1] Combined interferon-α and interleukin 2 as adjuvant treatment for melanoma
    Dummer, R
    Hauschild, A
    Henseler, T
    Burg, G
    LANCET, 1998, 352 (9131): : 908 - 909
  • [2] Radiotherapy and Immunotherapy, Combined Treatment for Unresectable Mucosal Melanoma with Vaginal Origin
    Rebegea, Laura
    Firescu, Dorel
    Stoleriu, Gabriela
    Arbune, Manuela
    Anghel, Rodica
    Dumitru, Mihaela
    Mihailov, Raul
    Neagu, Anca Iulia
    Bacinschi, Xenia
    APPLIED SCIENCES-BASEL, 2022, 12 (15):
  • [3] Perilesional treatment of metastatic melanoma with interferon-β
    Fujimura, T.
    Okuyama, R.
    Ohtani, T.
    Ito, Y.
    Haga, T.
    Hashimoto, A.
    Aiba, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (07) : 793 - 799
  • [4] Development of BOOP with interferon-β treatment for malignant melanoma
    Kimura, Y.
    Okuyama, R.
    Watanabe, H.
    Ashino, Y.
    Tagami, H.
    Aiba, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (08) : 999 - 1000
  • [5] The use of interferon-α in the treatment of cutaneous melanoma:: a review
    Punt, CJA
    MELANOMA RESEARCH, 1998, 8 (02) : 95 - 104
  • [6] Combined treatment with pegylated interferon-α-2a and dacarbazine in patients with advanced metastatic melanoma
    Hauschild, Axel
    Dummer, Reinhard
    Ugurel, Selma
    Kaehler, Katharina C.
    Egberts, Friederike
    Fink, Wolfram
    Both-Skalsky, Jeannine
    Laetsch, Barbara
    Schadendorf, Dirk
    CANCER, 2008, 113 (06) : 1404 - 1411
  • [7] Combined treatment with histamine dihydrochloride, interleukin-2 and interferon-α in patients with metastatic melanoma
    Lindnér, P
    Rizell, M
    Mattsson, J
    Hellstrand, K
    Naredi, P
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1837 - 1842
  • [8] Interferon-α therapy for melanoma
    Russell-Jones, R
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (01) : 1 - 6
  • [9] Combined treatment with thymosin-α1 and low dose interferon-α after dacarbazine in advanced melanoma
    Rasi, G
    Terzoli, E
    Izzo, F
    Pierimarchi, P
    Ranuzzi, M
    Sinibaldi-Vallebona, P
    Tuthill, C
    Garaci, E
    MELANOMA RESEARCH, 2000, 10 (02) : 189 - 192
  • [10] Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-α
    Konjevic, G
    Jovic, V
    Radulovic, S
    Jelic, S
    Dzodic, R
    Spuzic, I
    NEOPLASMA, 2001, 48 (03) : 175 - 181
12345